ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryAllschwilMerz Pharma (Schweiz) AG
Merz Pharma (Schweiz) AG Logo
Verified· 3 sources

Merz Pharma (Schweiz) AG

Summary

About the company

The core activity of Merz Therapeutics is the development, manufacture and marketing of pharmaceuticals, particularly in the fields of neurology, hepatology and dermatology. The company focuses on researching and developing innovative therapies to improve the quality of life for patients.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered6
Specialty Neurology
Innovative medicines and therapies for neurological diseases such as Parkinson’s, multiple sclerosis, dystonia, spasticity, sialorrhea, Alzheimer’s and vocal fold insufficiency.
Hepatology
Treatment options for chronic liver diseases, in particular to support impaired detoxification capacity and hepatic encephalopathy.
Dermatology
Medicines for scars and hair loss, including Contractubex for scar management and Pantogar for diffuse hair loss.
Commercial Partnerships
Licensing, distribution and marketing partnerships for the specialty portfolio in neurology as well as for established growth brands in hepatology and dermatology.
Business and Corporate Development
Partnerships and acquisitions along the entire therapeutic lifecycle, with a focus on Phase 2, Phase 3 and marketed opportunities in Specialty Neuroscience.
Research and Pipeline
Development of innovative medicines, in particular late-stage clinical programs and new indications for Incobotulinumtoxin A (XEOMIN®) in neurology and pain.
Press

Media

August 3, 2020Media
Wirbel um Haarmedikament: Pharma-Hersteller Merz wird im Hauptanklagepunkt entlastet
bzbasel.ch
Comparisons

Merz Pharma (Schweiz) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Merz Pharma (Schweiz) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Merz Pharma (Schweiz) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 57
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-101.213.674
Founded
1977 · 49 years
Last commercial register change
January 23, 2026
Employees
51 to 100

Knowledge

No knowledge articles yet

Once Merz Pharma (Schweiz) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

MA
Merz Aesthetics (Schweiz) AG
Allschwil
TP
T3 Pharmaceuticals AG
Allschwil
AP
Actelion Pharmaceuticals Ltd
Allschwil
MG
MiHKAL GmbH
Allschwil
NS
Neurocrine Switzerland GmbH
Allschwil
AS
AlphaMol Science AG
Allschwil
BA
Biolytix AG
Dittingen
CA
Curatis AG
Liestal